These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21593861)

  • 1. Cardiovascular biology.
    Thomas C
    Nature; 2011 May; 473(7347):297. PubMed ID: 21593861
    [No Abstract]   [Full Text] [Related]  

  • 2. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
    Wong TY
    Am J Ophthalmol; 2009 Sep; 148(3):327-9. PubMed ID: 19703607
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care].
    Khalaim AV; Stoliarenko GE
    Vestn Oftalmol; 2007; 123(5):54-6, preceding 56. PubMed ID: 18078062
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular actions of insulin with implications for endothelial dysfunction.
    Potenza MA; Addabbo F; Montagnani M
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E568-77. PubMed ID: 19491294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal anti-angiogenesis by a new route.
    Bicknell R
    Nat Biotechnol; 2008 May; 26(5):528-9. PubMed ID: 18464784
    [No Abstract]   [Full Text] [Related]  

  • 6. Defining vascular aging and cardiovascular risk.
    Laurent S
    J Hypertens; 2012 Jun; 30 Suppl():S3-8. PubMed ID: 23124102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and clinical applications of angiogenesis.
    Carmeliet P; Jain RK
    Nature; 2011 May; 473(7347):298-307. PubMed ID: 21593862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of matrix metalloproteinases in vascular biology].
    Sela BA
    Harefuah; 2001 Feb; 140(2):134-8. PubMed ID: 11242919
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-angiogenesis targeting drugs: a review].
    Jia K; Li J
    Ai Zheng; 2008 Apr; 27(4):442-6. PubMed ID: 18423135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
    Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
    Griffioen AW; Molema G
    Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes.
    Ceriello A
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S15-9. PubMed ID: 20489415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-VEGF therapy: a new approach to colorectal cancer therapy.
    Carrato A; Gallego-Plazas J; Guillen-Ponce C
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1385-96. PubMed ID: 17069524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factors in cardiovascular medicine.
    Testa U; Pannitteri G; Condorelli GL
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1190-221. PubMed ID: 19001927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of vascular reactivity: prognostic crystal ball or Pandora's box?
    Minson CT; Green DJ
    J Appl Physiol (1985); 2008 Aug; 105(2):398-9. PubMed ID: 18556427
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.